BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
McKesson
Cerilliant
AstraZeneca
Boehringer Ingelheim
UBS
US Department of Justice
Farmers Insurance
Healthtrust

Generated: January 21, 2018

DrugPatentWatch Database Preview

Allopurinol - Generic Drug Details

« Back to Dashboard

What are the generic sources for allopurinol and what is the scope of allopurinol patent protection?

Allopurinol
is the generic ingredient in six branded drugs marketed by Accord Hlthcare, Apotex Inc, Indoco Remedies, Ipca Labs Ltd, Mutual Pharm, Mylan, Northstar Hlthcare, Puracap Pharm, Purepac Pharm, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Vintage Pharms, Watson Labs, Zydus Pharms Usa Inc, Abbott, Dr Reddys La, Casper Pharma Llc, West-ward Pharms Int, Mylan Institutional, and Ironwood Pharms Inc, and is included in thirty-two NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for allopurinol. Forty-five suppliers are listed for this compound.
Pharmacology for allopurinol
Medical Subject Heading (MeSH) Categories for allopurinol

US Patents and Regulatory Information for allopurinol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm ALLOPURINOL allopurinol TABLET;ORAL 070580-001 Apr 14, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vintage Pharms ALLOPURINOL allopurinol TABLET;ORAL 075798-002 Jun 27, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan ALLOPURINOL allopurinol TABLET;ORAL 018659-001 Oct 24, 1986 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc ALLOPURINOL allopurinol TABLET;ORAL 078390-001 Aug 30, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ironwood Pharms Inc DUZALLO allopurinol; lesinurad TABLET;ORAL 209203-002 Aug 18, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ironwood Pharms Inc DUZALLO allopurinol; lesinurad TABLET;ORAL 209203-002 Aug 18, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mutual Pharm ALLOPURINOL allopurinol TABLET;ORAL 070466-001 Dec 24, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ALLOPURINOL allopurinol TABLET;ORAL 018241-001 Nov 16, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare ALLOPURINOL allopurinol TABLET;ORAL 203154-001 May 6, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Puracap Pharm ALLOPURINOL allopurinol TABLET;ORAL 070147-001 Dec 10, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for allopurinol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott LOPURIN allopurinol TABLET;ORAL 018297-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Abbott LOPURIN allopurinol TABLET;ORAL 018297-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Fuji
Federal Trade Commission
Teva
Colorcon
Harvard Business School
Accenture
UBS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot